Abstract
The role of different cytokines and cells of immune system in the pathogenesis of chronic GVHD (cGVHD) is still controversial. Earlier studies, which were either retrospective or analysed one or a few factors, did not show unequivocal results. We prospectively evaluated cytokine levels and lymphocyte subsets in 30 patients who underwent Allo-SCT to investigate their possible correlation with cGVHD. Levels of IL-4, IL-6, IL-10, IFN-γ, tumour necrosis factor-alpha (TNF-α) and its soluble receptors were assessed by ELISA in 30 patients at different times after SCT. Lymphocyte subsets were evaluated by flow cytometry in peripheral blood at the same times as cytokines. A multivariate analysis was performed using principal component analysis and multi-factor ANOVA (analysis of variance). Eighteen patients developed cGVHD at a median time of 6 months (range, 5–9) after SCT. In multivariate analysis, we observed a correlation between cGVHD and clusters of cytokines and lymphocyte subsets from the third to the sixth month after SCT. These clusters changed their composition over time, but they constantly included natural killer (NK) and CD152+ T cells as negative predictors of cGVHD. TNF-α prevailed among other cytokines before the onset of cGVHD. This prevalence could be related partly to the defect of immunoregulatory cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Higman MA, Vogelsang GB . Chronic graft versus host disease. Br J Haematol 2004; 125: 435–454.
Barrett AJ, Rezvani K, Solomon S, Dickinson AM, Wang XN, Stark G et al. New developments in allotransplant immunology. Hematology Am Soc Hematol Educ Program 2003, 350–371.
Sherer Y, Shoenfeld Y . Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998; 22: 873–881.
Wood KJ, Sakaguchi S . Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199–210.
Zorn E . CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation. Semin Cancer Biol 2006; 16: 150–159.
Shindo T, Ishikawa T, Fukunaga A, Hori T, Uchiyama T . Growth and differentiation advantages of CD4+OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2008; 14: 268–281.
O’Shea JJ, Ma A, Lipsky P . Cytokines and autoimmunity. Nat Rev Immunol 2002; 2: 37–45.
Salomon B, Bluestone JA . Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225–252.
Fimiani M, De Aloe G, Cuccia A . Chronic graft versus host disease and skin. J Eur Acad Dermatol Venerol 2003; 17: 512–517.
Imamura M, Hashino S, Kobayashi H, Kubayashi S, Hirano S, Minagawa T et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease. Bone Marrow Transplant 1994; 13: 745–751.
Barak V, Levi-Schaffer F, Nisman B, Nagler A . Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma 1995; 17: 169–173.
Ritchie D, Seconi J, Wood C, Walton J, Watt V . Prospective monitoring of tumor necrosis factor á and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 706–712.
Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC . Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002; 168: 3088–3098.
Bell SA, Faust H, Mittermüller J, Kolb HJ, Meurer M . Specificity of anti-nuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Haematol 1996; 134: 848–854.
Skert C, Patriarca F, Sperotto A, Cerno M, Filì C, Zaja F et al. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica 2006; 91: 258–261.
Patriarca F, Skert C, Sperotto A, Zaja F, Falleti E, Mestroni R et al. The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. Exp Hematol 2006; 34: 389–396.
Janin A, Socie G, Devergie A, Aractingi S, Esperou H, Verola O et al. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Ann Intern Med 1994; 120: 993–998.
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man: a long term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Lee SJ, Vogelsang G, Flowers ME . Chronic graft versus host disease. Biol Blood Marrow Transplant 2003; 9: 215–233.
Jolliffe IT . Principal component analysis. Springer 2002.
Kachigan SK . Statistical analysis. Radius Press: New York, 1986.
Liem LM, van Houwelingen HC, Goulmy E . Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation 1998; 15: 863–871.
Yamashita K, Choi U, Woltz PC, Foster SF, Sneller FC, Hakim FT et al. Severe chronic graft-versus-host disease is characterized by a preponderance of CD4+effector memory cells relative to central memory cells. Blood 2004; 103: 3986–3988.
Kotani A, Ishikawa T, Matsumura Y, Ichinohe T, Ohno H, Hori T et al. Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3162–3164.
Meignin V, de Latour RP, Zuber J, Règnault A, Mounier N, Lemaitre F et al. Numbers of FOXp3-expressing CD4+CD25 high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation. Exp Hematol 2005; 33: 894–900.
Clark FJ, Gregg R, Piper K, Dunnion D, Freeman L, Griffiths M et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25 high regulatory T cells. Blood 2004; 103: 2410–2416.
Imamura M, Tsutsumi Y, Miura Y, Toubai T, Tanaka J . Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation. Hematology 2003; 8: 19–26.
Shenoy S, Mohanakumar T, Todd G, Westhoff W, Dunnigan K, Adkins DR et al. Immune reconstitution following allogeneic peripheral blood stem cell transplants. Bone Marrow Transplant 1999; 23: 335–346.
Pazmany L . Do NK cells regulate human autoimmunity? Cytokine 2005; 32: 76–80.
Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E . Natural-killer cells and dendritic cells: l’union fait la force’. Blood 2005; 106: 2252–2258.
Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–2100.
Anderson BE, McNiff JM, Jain D, Blazar BR, Shlomchik WD, Shlomchik MJ . Distinct roles for donor-and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood 2005; 105: 2227–2234.
Wilson JL, Heffler LC, Charo J, Scheynius A, Bejarano MT, Ljunggren HG . Targeting of human dendritic cells by autologous NK cells. J Immunol 1999; 163: 6365–6370.
Salazar-Fontana LI, Bierer BE . T-lymphocyte coactivator molecules. Curr Opin Hematol 2001; 8: 5–11.
Clarkson MR, Sayegh MH . T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 2005; 80: 555–563.
Cope AP . Regulation of autoimmunity by proinflammatory cytokines. Curr Opin Immunol 1998; 10: 669–676.
Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft versus-host-disease. Blood 2005; 106: 2903–2911.
Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM . The dual role of IL-10. Trends Immunol 2003; 24: 36–43.
Groux H, Cottrez F . The complex role of interleukin-10 in autoimmunity. J Autoimmun 2003; 20: 281–285.
Groux H, Bigler M, de Vries JE, Roncarolo MG . Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol 1998; 160: 3188–3193.
Hill N, Sarvetnick N . Cytokines: promoters and dampeners of autoimmunity. Curr Opin Immunol 2002; 14: 791–797.
Fujii H, Cuvelier G, She K, Aslanian S, Shimizu H, Kariminia A et al. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood 2008; 111: 3276–3285.
Acknowledgements
This work was supported by Project Regione Lombardia-Piano regionale sangue.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Skert, C., Damiani, D., Michelutti, A. et al. Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. Bone Marrow Transplant 44, 729–737 (2009). https://doi.org/10.1038/bmt.2009.80
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.80
Keywords
This article is cited by
-
Biologic markers of chronic GVHD
Bone Marrow Transplantation (2014)
-
Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?
Bone Marrow Transplantation (2013)
-
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity
Leukemia (2012)
-
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation
Bone Marrow Transplantation (2010)